Status:
UNKNOWN
Universal Hemoglobin A1c Versus Risk-based Screening for Early Gestational Diabetes Mellitus (EARLY GDM): A Randomized Controlled Trial
Lead Sponsor:
Thomas Jefferson University
Conditions:
Gestational Diabetes
Large for Gestational Age
Eligibility:
FEMALE
18-50 years
Phase:
NA
Brief Summary
The goal of this randomized controlled trial is to compare the rate of large-for-gestational-age neonates between universal screening with glycated hemoglobin (A1C) and early risk-based screening with...
Eligibility Criteria
Inclusion
- Presenting to prenatal care ≤16 6/7 weeks of gestation
- Intend to deliver at TJUH
Exclusion
- Multifetal gestation
- Pre-pregnancy diagnosis of diabetes mellitus
- History of malabsorptive gastric bypass surgery
- Hemoglobinopathy
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
770 Patients enrolled
Trial Details
Trial ID
NCT06190405
Start Date
January 1 2024
End Date
June 1 2025
Last Update
January 5 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.